{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:43:37Z","timestamp":1793299417636,"version":"4.5.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T00:00:00Z","timestamp":1453766400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100012166","name":"973 program","doi-asserted-by":"crossref","award":["2011CB504102"],"award-info":[{"award-number":["2011CB504102"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81430024"],"award-info":[{"award-number":["81430024"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31471114"],"award-info":[{"award-number":["31471114"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of China","doi-asserted-by":"crossref","award":["20123706120002"],"award-info":[{"award-number":["20123706120002"]}],"id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Bureau of Science and Technology of Qingdao","award":["14-2-4-72-jch"],"award-info":[{"award-number":["14-2-4-72-jch"]}]},{"name":"Taishan Scholars Construction Project"},{"DOI":"10.13039\/501100004602","name":"Program for New Century Excellent Talents in University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s12035-016-9729-1","type":"journal-article","created":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T08:19:18Z","timestamp":1453796358000},"page":"1144-1155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Ghrelin and Neurodegenerative Disorders\u2014a Review"],"prefix":"10.1007","volume":"54","author":[{"given":"Limin","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,26]]},"reference":[{"issue":"6762","key":"9729_CR1","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/45230","volume":"402","author":"M Kojima","year":"1999","unstructured":"Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402(6762):656\u2013660. doi: 10.1038\/45230","journal-title":"Nature"},{"issue":"1","key":"9729_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2174\/157015909787602779","volume":"7","author":"F Ferrini","year":"2009","unstructured":"Ferrini F, Salio C, Lossi L, Merighi A (2009) Ghrelin in central neurons. Curr Neuropharmacol 7(1):37\u201349. doi: 10.2174\/157015909787602779","journal-title":"Curr Neuropharmacol"},{"issue":"6","key":"9729_CR3","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1210\/en.2005-0174","volume":"146","author":"T Sato","year":"2005","unstructured":"Sato T, Fukue Y, Teranishi H, Yoshida Y, Kojima M (2005) Molecular forms of hypothalamic ghrelin and its regulation by fasting and 2-deoxy-d-glucose administration. Endocrinology 146(6):2510\u20132516. doi: 10.1210\/en.2005-0174","journal-title":"Endocrinology"},{"issue":"4","key":"9729_CR4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0896-6273(03)00063-1","volume":"37","author":"MA Cowley","year":"2003","unstructured":"Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, Horvath TL (2003) The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37(4):649\u2013661","journal-title":"Neuron"},{"issue":"2-3","key":"9729_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.regpep.2006.02.005","volume":"134","author":"Z Hou","year":"2006","unstructured":"Hou Z, Miao Y, Gao L, Pan H, Zhu S (2006) Ghrelin-containing neuron in cerebral cortex and hypothalamus linked with the DVC of brainstem in rat. Regul Pept 134(2-3):126\u2013131. doi: 10.1016\/j.regpep.2006.02.005","journal-title":"Regul Pept"},{"issue":"2","key":"9729_CR6","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1210\/jcem.86.2.7190","volume":"86","author":"M Korbonits","year":"2001","unstructured":"Korbonits M, Bustin SA, Kojima M, Jordan S, Adams EF, Lowe DG, Kangawa K, Grossman AB (2001) The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J Clin Endocrinol Metab 86(2):881\u2013887. doi: 10.1210\/jcem.86.2.7190","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"9729_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1152\/physrev.00012.2004","volume":"85","author":"M Kojima","year":"2005","unstructured":"Kojima M, Kangawa K (2005) Ghrelin: structure and function. Physiol Rev 85(2):495\u2013522. doi: 10.1152\/physrev.00012.2004","journal-title":"Physiol Rev"},{"issue":"3","key":"9729_CR8","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/cne.20823","volume":"494","author":"JM Zigman","year":"2006","unstructured":"Zigman JM, Jones JE, Lee CE, Saper CB, Elmquist JK (2006) Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol 494(3):528\u2013548. doi: 10.1002\/cne.20823","journal-title":"J Comp Neurol"},{"issue":"1","key":"9729_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.tins.2010.10.001","volume":"34","author":"ZB Andrews","year":"2011","unstructured":"Andrews ZB (2011) The extra-hypothalamic actions of ghrelin on neuronal function. Trends Neurosci 34(1):31\u201340. doi: 10.1016\/j.tins.2010.10.001","journal-title":"Trends Neurosci"},{"key":"9729_CR10","doi-asserted-by":"crossref","unstructured":"Bali A, Jaggi AS (2015) An integrative review on role and mechanisms of ghrelin in stress, anxiety and depression. Curr Drug Targets.","DOI":"10.2174\/1389450116666150518095650"},{"issue":"8","key":"9729_CR11","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/nure.12045","volume":"71","author":"B Beck","year":"2013","unstructured":"Beck B, Pourie G (2013) Ghrelin, neuropeptide Y, and other feeding-regulatory peptides active in the hippocampus: role in learning and memory. Nutr Rev 71(8):541\u2013561. doi: 10.1111\/nure.12045","journal-title":"Nutr Rev"},{"issue":"1","key":"9729_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.mce.2011.02.017","volume":"340","author":"SL Dickson","year":"2011","unstructured":"Dickson SL, Egecioglu E, Landgren S, Skibicka KP, Engel JA, Jerlhag E (2011) The role of the central ghrelin system in reward from food and chemical drugs. Mol Cell Endocrinol 340(1):80\u201387. doi: 10.1016\/j.mce.2011.02.017","journal-title":"Mol Cell Endocrinol"},{"issue":"45","key":"9729_CR13","doi-asserted-by":"publisher","first-page":"14057","DOI":"10.1523\/JNEUROSCI.3890-09.2009","volume":"29","author":"ZB Andrews","year":"2009","unstructured":"Andrews ZB, Erion D, Beiler R, Liu ZW, Abizaid A, Zigman J, Elsworth JD, Savitt JM, DiMarchi R, Tschoep M, Roth RH, Gao XB, Horvath TL (2009) Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism. J Neurosci 29(45):14057\u201314065. doi: 10.1523\/JNEUROSCI.3890-09.2009","journal-title":"J Neurosci"},{"issue":"11","key":"9729_CR14","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.peptides.2011.09.019","volume":"32","author":"MD Gahete","year":"2011","unstructured":"Gahete MD, Cordoba-Chacon J, Kineman RD, Luque RM, Castano JP (2011) Role of ghrelin system in neuroprotection and cognitive functions: implications in Alzheimer\u2019s disease. Peptides 32(11):2225\u20132228. doi: 10.1016\/j.peptides.2011.09.019","journal-title":"Peptides"},{"issue":"2","key":"9729_CR15","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.expneurol.2008.05.006","volume":"212","author":"H Jiang","year":"2008","unstructured":"Jiang H, Li LJ, Wang J, Xie JX (2008) Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra. Exp Neurol 212(2):532\u2013537. doi: 10.1016\/j.expneurol.2008.05.006","journal-title":"Exp Neurol"},{"issue":"38","key":"9729_CR16","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.2174\/13816128113199990411","volume":"19","author":"VV Santos Dos","year":"2013","unstructured":"Dos Santos VV, Rodrigues AL, De Lima TC, de Barioglio SR, Raisman-Vozari R, Prediger RD (2013) Ghrelin as a neuroprotective and palliative agent in Alzheimer\u2019s and Parkinson\u2019s disease. Curr Pharm Des 19(38):6773\u20136790","journal-title":"Curr Pharm Des"},{"key":"9729_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neuroscience.2013.02.062","volume":"241","author":"I Martins","year":"2013","unstructured":"Martins I, Gomes S, Costa RO, Otvos L, Oliveira CR, Resende R, Pereira CM (2013) Leptin and ghrelin prevent hippocampal dysfunction induced by Abeta oligomers. Neuroscience 241:41\u201351. doi: 10.1016\/j.neuroscience.2013.02.062","journal-title":"Neuroscience"},{"issue":"4","key":"9729_CR18","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s12640-009-9037-x","volume":"15","author":"M Moon","year":"2009","unstructured":"Moon M, Kim HG, Hwang L, Seo JH, Kim S, Hwang S, Lee D, Chung H, Oh MS, Lee KT, Park S (2009) Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease by blocking microglial activation. Neurotox Res 15(4):332\u2013347. doi: 10.1007\/s12640-009-9037-x","journal-title":"Neurotox Res"},{"issue":"1","key":"9729_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3233\/JAD-2010-101263","volume":"23","author":"M Moon","year":"2011","unstructured":"Moon M, Choi JG, Nam DW, Hong HS, Choi YJ, Oh MS, Mook-Jung I (2011) Ghrelin ameliorates cognitive dysfunction and neurodegeneration in intrahippocampal amyloid-beta1-42 oligomer-injected mice. J Alzheimers Dis 23(1):147\u2013159. doi: 10.3233\/JAD-2010-101263","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"9729_CR20","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1600-0404.2009.01185.x","volume":"121","author":"U Fiszer","year":"2010","unstructured":"Fiszer U, Michalowska M, Baranowska B, Wolinska-Witort E, Jeske W, Jethon M, Piascik-Gromada M, Marcinowska-Suchowierska E (2010) Leptin and ghrelin concentrations and weight loss in Parkinson\u2019s disease. Acta Neurol Scand 121(4):230\u2013236. doi: 10.1111\/j.1600-0404.2009.01185.x","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"9729_CR21","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s00415-010-5864-1","volume":"258","author":"MM Unger","year":"2011","unstructured":"Unger MM, Moller JC, Mankel K, Eggert KM, Bohne K, Bodden M, Stiasny-Kolster K, Kann PH, Mayer G, Tebbe JJ, Oertel WH (2011) Postprandial ghrelin response is reduced in patients with Parkinson\u2019s disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson\u2019s disease? J Neurol 258(6):982\u2013990. doi: 10.1007\/s00415-010-5864-1","journal-title":"J Neurol"},{"issue":"2","key":"9729_CR22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.14802\/jmd.15003","volume":"8","author":"HM Lee","year":"2015","unstructured":"Lee HM, Koh SB (2015) Many faces of Parkinson\u2019s disease: non-motor symptoms of Parkinson\u2019s disease. J Mov Disord 8(2):92\u201397. doi: 10.14802\/jmd.15003","journal-title":"J Mov Disord"},{"issue":"Suppl 2","key":"9729_CR23","doi-asserted-by":"publisher","first-page":"S656","DOI":"10.1002\/mds.22672","volume":"24","author":"C Gaig","year":"2009","unstructured":"Gaig C, Tolosa E (2009) When does Parkinson\u2019s disease begin? Mov Disord 24(Suppl 2):S656\u2013S664. doi: 10.1002\/mds.22672","journal-title":"Mov Disord"},{"issue":"1","key":"9729_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1369-1600.2006.00002.x","volume":"11","author":"E Jerlhag","year":"2006","unstructured":"Jerlhag E, Egecioglu E, Dickson SL, Andersson M, Svensson L, Engel JA (2006) Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward. Addict Biol 11(1):45\u201354. doi: 10.1111\/j.1369-1600.2006.00002.x","journal-title":"Addict Biol"},{"issue":"2-3","key":"9729_CR25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.drugalcdep.2011.01.010","volume":"117","author":"E Jerlhag","year":"2011","unstructured":"Jerlhag E, Engel JA (2011) Ghrelin receptor antagonism attenuates nicotine-induced locomotor stimulation, accumbal dopamine release and conditioned place preference in mice. Drug Alcohol Depend 117(2-3):126\u2013131. doi: 10.1016\/j.drugalcdep.2011.01.010","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"9729_CR26","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1172\/JCI29867","volume":"116","author":"A Abizaid","year":"2006","unstructured":"Abizaid A, Liu ZW, Andrews ZB, Shanabrough M, Borok E, Elsworth JD, Roth RH, Sleeman MW, Picciotto MR, Tschop MH, Gao XB, Horvath TL (2006) Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest 116(12):3229\u20133239. doi: 10.1172\/JCI29867","journal-title":"J Clin Invest"},{"issue":"1","key":"9729_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1369-1600.2006.00041.x","volume":"12","author":"E Jerlhag","year":"2007","unstructured":"Jerlhag E, Egecioglu E, Dickson SL, Douhan A, Svensson L, Engel JA (2007) Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict Biol 12(1):6\u201316. doi: 10.1111\/j.1369-1600.2006.00041.x","journal-title":"Addict Biol"},{"issue":"3-4","key":"9729_CR28","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1369-1600.2008.00125.x","volume":"13","author":"E Jerlhag","year":"2008","unstructured":"Jerlhag E (2008) Systemic administration of ghrelin induces conditioned place preference and stimulates accumbal dopamine. Addict Biol 13(3-4):358\u2013363. doi: 10.1111\/j.1369-1600.2008.00125.x","journal-title":"Addict Biol"},{"issue":"2","key":"9729_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuint.2008.12.006","volume":"54","author":"D Quarta","year":"2009","unstructured":"Quarta D, Di Francesco C, Melotto S, Mangiarini L, Heidbreder C, Hedou G (2009) Systemic administration of ghrelin increases extracellular dopamine in the shell but not the core subdivision of the nucleus accumbens. Neurochem Int 54(2):89\u201394. doi: 10.1016\/j.neuint.2008.12.006","journal-title":"Neurochem Int"},{"issue":"8","key":"9729_CR30","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1210\/me.2005-0084","volume":"20","author":"H Jiang","year":"2006","unstructured":"Jiang H, Betancourt L, Smith RG (2006) Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor\/dopamine receptor subtype 1 heterodimers. Mol Endocrinol 20(8):1772\u20131785. doi: 10.1210\/me.2005-0084","journal-title":"Mol Endocrinol"},{"issue":"2","key":"9729_CR31","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s12031-008-9162-7","volume":"37","author":"J Dong","year":"2009","unstructured":"Dong J, Song N, Xie J, Jiang H (2009) Ghrelin antagonized 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells. J Mol Neurosci 37(2):182\u2013189. doi: 10.1007\/s12031-008-9162-7","journal-title":"J Mol Neurosci"},{"issue":"1","key":"9729_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.expneurol.2009.11.009","volume":"222","author":"L Liu","year":"2010","unstructured":"Liu L, Xu H, Jiang H, Wang J, Song N, Xie J (2010) Ghrelin prevents 1-methyl-4-phenylpyridinium ion-induced cytotoxicity through antioxidation and NF-kappaB modulation in MES23.5 cells. Exp Neurol 222(1):25\u201329. doi: 10.1016\/j.expneurol.2009.11.009","journal-title":"Exp Neurol"},{"issue":"1","key":"9729_CR33","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1210\/en.2006-0991","volume":"148","author":"H Chung","year":"2007","unstructured":"Chung H, Kim E, Lee DH, Seo S, Ju S, Lee D, Kim H, Park S (2007) Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation. Endocrinology 148(1):148\u2013159. doi: 10.1210\/en.2006-0991","journal-title":"Endocrinology"},{"issue":"3","key":"9729_CR34","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.bbrc.2007.05.192","volume":"359","author":"Y Miao","year":"2007","unstructured":"Miao Y, Xia Q, Hou Z, Zheng Y, Pan H, Zhu S (2007) Ghrelin protects cortical neuron against focal ischemia\/reperfusion in rats. Biochem Biophys Res Commun 359(3):795\u2013800. doi: 10.1016\/j.bbrc.2007.05.192","journal-title":"Biochem Biophys Res Commun"},{"issue":"7206","key":"9729_CR35","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/nature07181","volume":"454","author":"ZB Andrews","year":"2008","unstructured":"Andrews ZB, Liu ZW, Walllingford N, Erion DM, Borok E, Friedman JM, Tschop MH, Shanabrough M, Cline G, Shulman GI, Coppola A, Gao XB, Horvath TL, Diano S (2008) UCP2 mediates ghrelin\u2019s action on NPY\/AgRP neurons by lowering free radicals. Nature 454(7206):846\u2013851. doi: 10.1038\/nature07181","journal-title":"Nature"},{"issue":"11","key":"9729_CR36","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.1210\/en.2003-0667","volume":"144","author":"S Diano","year":"2003","unstructured":"Diano S, Matthews RT, Patrylo P, Yang L, Beal MF, Barnstable CJ, Horvath TL (2003) Uncoupling protein 2 prevents neuronal death including that occurring during seizures: a mechanism for preconditioning. Endocrinology 144(11):5014\u20135021. doi: 10.1210\/en.2003-0667","journal-title":"Endocrinology"},{"issue":"1","key":"9729_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/2042018813479645","volume":"4","author":"JA Bayliss","year":"2013","unstructured":"Bayliss JA, Andrews ZB (2013) Ghrelin is neuroprotective in Parkinson\u2019s disease: molecular mechanisms of metabolic neuroprotection. Ther Adv Endocrinol Metab 4(1):25\u201336. doi: 10.1177\/2042018813479645","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"3","key":"9729_CR38","doi-asserted-by":"publisher","first-page":"R485","DOI":"10.1152\/ajpregu.90555.2008","volume":"296","author":"M Fry","year":"2009","unstructured":"Fry M, Ferguson AV (2009) Ghrelin modulates electrical activity of area postrema neurons. Am J Physiol Regul Integr Comp Physiol 296(3):R485\u2013R492. doi: 10.1152\/ajpregu.90555.2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"7","key":"9729_CR39","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1523\/JNEUROSCI.3218-05.2006","volume":"26","author":"KJ Pulman","year":"2006","unstructured":"Pulman KJ, Fry WM, Cottrell GT, Ferguson AV (2006) The subfornical organ: a central target for circulating feeding signals. J Neurosci 26(7):2022\u20132030. doi: 10.1523\/JNEUROSCI.3218-05.2006","journal-title":"J Neurosci"},{"issue":"4","key":"9729_CR40","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.peptides.2008.12.004","volume":"30","author":"J Kim","year":"2009","unstructured":"Kim J, Nakajima K, Oomura Y, Wayner MJ, Sasaki K (2009) Electrophysiological effects of ghrelin on pedunculopontine tegmental neurons in rats: an in vitro study. Peptides 30(4):745\u2013757. doi: 10.1016\/j.peptides.2008.12.004","journal-title":"Peptides"},{"issue":"1","key":"9729_CR41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/187152706784111542","volume":"5","author":"M Marinelli","year":"2006","unstructured":"Marinelli M, Rudick CN, Hu XT, White FJ (2006) Excitability of dopamine neurons: modulation and physiological consequences. CNS Neurol Disord: Drug Targets 5(1):79\u201397","journal-title":"CNS Neurol Disord: Drug Targets"},{"issue":"3","key":"9729_CR42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0028-3908(01)00192-7","volume":"42","author":"S Prisco","year":"2002","unstructured":"Prisco S, Natoli S, Bernardi G, Mercuri NB (2002) Group I metabotropic glutamate receptors activate burst firing in rat midbrain dopaminergic neurons. Neuropharmacology 42(3):289\u2013296","journal-title":"Neuropharmacology"},{"key":"9729_CR43","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1038\/ncomms2439","volume":"4","author":"L Shi","year":"2013","unstructured":"Shi L, Bian X, Qu Z, Ma Z, Zhou Y, Wang K, Jiang H, Xie J (2013) Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7\/KCNQ channels. Nat Commun 4:1435. doi: 10.1038\/ncomms2439","journal-title":"Nat Commun"},{"issue":"2","key":"9729_CR44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24(2):197\u2013211","journal-title":"Neurobiol Aging"},{"issue":"12","key":"9729_CR45","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1002\/mds.21065","volume":"21","author":"H Braak","year":"2006","unstructured":"Braak H, Bohl JR, Muller CM, Rub U, de Vos RA, Del Tredici K (2006) Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson\u2019s disease reconsidered. Mov Disord 21(12):2042\u20132051. doi: 10.1002\/mds.21065","journal-title":"Mov Disord"},{"issue":"4","key":"9729_CR46","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00401-007-0193-x","volume":"113","author":"H Braak","year":"2007","unstructured":"Braak H, Sastre M, Bohl JR, de Vos RA, Del Tredici K (2007) Parkinson\u2019s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol 113(4):421\u2013429. doi: 10.1007\/s00401-007-0193-x","journal-title":"Acta Neuropathol"},{"issue":"5","key":"9729_CR47","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/ana.21541","volume":"64","author":"RE Burke","year":"2008","unstructured":"Burke RE, Dauer WT, Vonsattel JP (2008) A critical evaluation of the Braak staging scheme for Parkinson\u2019s disease. Ann Neurol 64(5):485\u2013491. doi: 10.1002\/ana.21541","journal-title":"Ann Neurol"},{"issue":"6","key":"9729_CR48","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","volume":"33","author":"CH Hawkes","year":"2007","unstructured":"Hawkes CH, Del Tredici K, Braak H (2007) Parkinson\u2019s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 33(6):599\u2013614. doi: 10.1111\/j.1365-2990.2007.00874.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"Suppl 2","key":"9729_CR49","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.3949\/ccjm.79.s2a.03","volume":"79","author":"HH Fernandez","year":"2012","unstructured":"Fernandez HH (2012) Nonmotor complications of Parkinson disease. Cleve Clin J Med 79(Suppl 2):S14\u2013S18. doi: 10.3949\/ccjm.79.s2a.03","journal-title":"Cleve Clin J Med"},{"issue":"3","key":"9729_CR50","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1212\/WNL.0b013e31827deb74","volume":"80","author":"TK Khoo","year":"2013","unstructured":"Khoo TK, Yarnall AJ, Duncan GW, Coleman S, O\u2019Brien JT, Brooks DJ, Barker RA, Burn DJ (2013) The spectrum of nonmotor symptoms in early Parkinson disease. Neurology 80(3):276\u2013281. doi: 10.1212\/WNL.0b013e31827deb74","journal-title":"Neurology"},{"issue":"5","key":"9729_CR51","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/mds.24954","volume":"27","author":"A Siderowf","year":"2012","unstructured":"Siderowf A, Lang AE (2012) Premotor Parkinson\u2019s disease: concepts and definitions. Mov Disord 27(5):608\u2013616. doi: 10.1002\/mds.24954","journal-title":"Mov Disord"},{"issue":"11","key":"9729_CR52","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/mds.22643","volume":"24","author":"P Barone","year":"2009","unstructured":"Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, Bottacchi E, Cannas A, Ceravolo G, Ceravolo R, Cicarelli G, Gaglio RM, Giglia RM, Iemolo F, Manfredi M, Meco G, Nicoletti A, Pederzoli M, Petrone A, Pisani A, Pontieri FE, Quatrale R, Ramat S, Scala R, Volpe G, Zappulla S, Bentivoglio AR, Stocchi F, Trianni G, Dotto PD (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson\u2019s disease. Mov Disord 24(11):1641\u20131649. doi: 10.1002\/mds.22643","journal-title":"Mov Disord"},{"key":"9729_CR53","doi-asserted-by":"publisher","first-page":"290195","DOI":"10.4061\/2011\/290195","volume":"2011","author":"N Hwynn","year":"2011","unstructured":"Hwynn N, Haq IU, Malaty IA, Resnick AS, Okun MS, Carew DS, Oyama G, Dai Y, Wu SS, Rodriguez RL, Jacobson CE, Fernandez HH (2011) The frequency of nonmotor symptoms among advanced Parkinson patients may depend on instrument used for assessment. Parkinsons Dis 2011:290195. doi: 10.4061\/2011\/290195","journal-title":"Parkinsons Dis"},{"issue":"2","key":"9729_CR54","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1474-4422(03)00307-7","volume":"2","author":"RF Pfeiffer","year":"2003","unstructured":"Pfeiffer RF (2003) Gastrointestinal dysfunction in Parkinson\u2019s disease. Lancet Neurol 2(2):107\u2013116","journal-title":"Lancet Neurol"},{"issue":"5","key":"9729_CR55","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.parkreldis.2011.12.004","volume":"18","author":"ZS Heetun","year":"2012","unstructured":"Heetun ZS, Quigley EM (2012) Gastroparesis and Parkinson\u2019s disease: a systematic review. Parkinsonism Relat Disord 18(5):433\u2013440. doi: 10.1016\/j.parkreldis.2011.12.004","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"9729_CR56","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/mds.25708","volume":"29","author":"S Marrinan","year":"2014","unstructured":"Marrinan S, Emmanuel AV, Burn DJ (2014) Delayed gastric emptying in Parkinson\u2019s disease. Mov Disord 29(1):23\u201332. doi: 10.1002\/mds.25708","journal-title":"Mov Disord"},{"issue":"3","key":"9729_CR57","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.nbd.2011.10.014","volume":"46","author":"MG Cersosimo","year":"2012","unstructured":"Cersosimo MG, Benarroch EE (2012) Pathological correlates of gastrointestinal dysfunction in Parkinson\u2019s disease. Neurobiol Dis 46(3):559\u2013564. doi: 10.1016\/j.nbd.2011.10.014","journal-title":"Neurobiol Dis"},{"issue":"4","key":"9729_CR58","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/jnc.12191","volume":"125","author":"SA Grathwohl","year":"2013","unstructured":"Grathwohl SA, Steiner JA, Britschgi M, Brundin P (2013) Mind the gut: secretion of alpha-synuclein by enteric neurons. J Neurochem 125(4):487\u2013490. doi: 10.1111\/jnc.12191","journal-title":"J Neurochem"},{"issue":"4","key":"9729_CR59","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11910-011-0204-0","volume":"11","author":"LJ Cloud","year":"2011","unstructured":"Cloud LJ, Greene JG (2011) Gastrointestinal features of Parkinson\u2019s disease. Curr Neurol Neurosci Rep 11(4):379\u2013384. doi: 10.1007\/s11910-011-0204-0","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"3","key":"9729_CR60","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrd2444","volume":"7","author":"GJ Sanger","year":"2008","unstructured":"Sanger GJ, Lee K (2008) Hormones of the gut-brain axis as targets for the treatment of upper gastrointestinal disorders. Nat Rev Drug Discov 7(3):241\u2013254. doi: 10.1038\/nrd2444","journal-title":"Nat Rev Drug Discov"},{"issue":"21","key":"9729_CR61","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1056\/NEJMoa012908","volume":"346","author":"DE Cummings","year":"2002","unstructured":"Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346(21):1623\u20131630. doi: 10.1056\/NEJMoa012908","journal-title":"N Engl J Med"},{"issue":"6817","key":"9729_CR62","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/35051587","volume":"409","author":"M Nakazato","year":"2001","unstructured":"Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S (2001) A role for ghrelin in the central regulation of feeding. Nature 409(6817):194\u2013198. doi: 10.1038\/35051587","journal-title":"Nature"},{"issue":"6806","key":"9729_CR63","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/35038090","volume":"407","author":"M Tschop","year":"2000","unstructured":"Tschop M, Smiley DL, Heiman ML (2000) Ghrelin induces adiposity in rodents. Nature 407(6806):908\u2013913. doi: 10.1038\/35038090","journal-title":"Nature"},{"issue":"11","key":"9729_CR64","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1210\/endo.141.11.7873","volume":"141","author":"AM Wren","year":"2000","unstructured":"Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts GH, Morgan DG, Ghatei MA, Bloom SR (2000) The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141(11):4325\u20134328. doi: 10.1210\/endo.141.11.7873","journal-title":"Endocrinology"},{"issue":"8","key":"9729_CR65","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1136\/gut.2005.065896","volume":"54","author":"T Kitazawa","year":"2005","unstructured":"Kitazawa T, De Smet B, Verbeke K, Depoortere I, Peeters TL (2005) Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro. Gut 54(8):1078\u20131084. doi: 10.1136\/gut.2005.065896","journal-title":"Gut"},{"issue":"3","key":"9729_CR66","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1006\/bbrc.2000.3568","volume":"276","author":"Y Masuda","year":"2000","unstructured":"Masuda Y, Tanaka T, Inomata N, Ohnuma N, Tanaka S, Itoh Z, Hosoda H, Kojima M, Kangawa K (2000) Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 276(3):905\u2013908. doi: 10.1006\/bbrc.2000.3568","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"9729_CR67","doi-asserted-by":"publisher","first-page":"G948","DOI":"10.1152\/ajpgi.00339.2001","volume":"282","author":"L Trudel","year":"2002","unstructured":"Trudel L, Tomasetto C, Rio MC, Bouin M, Plourde V, Eberling P, Poitras P (2002) Ghrelin\/motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat. Am J Physiol Gastrointest Liver Physiol 282(6):G948\u2013G952. doi: 10.1152\/ajpgi.00339.2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"9729_CR68","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1136\/gut.2004.060426","volume":"55","author":"J Tack","year":"2006","unstructured":"Tack J, Depoortere I, Bisschops R, Delporte C, Coulie B, Meulemans A, Janssens J, Peeters T (2006) Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut 55(3):327\u2013333. doi: 10.1136\/gut.2004.060426","journal-title":"Gut"},{"issue":"1","key":"9729_CR69","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1365-2982.2008.01179.x","volume":"21","author":"J Zheng","year":"2009","unstructured":"Zheng J, Ariga H, Taniguchi H, Ludwig K, Takahashi T (2009) Ghrelin regulates gastric phase III-like contractions in freely moving conscious mice. Neurogastroenterol Motil 21(1):78\u201384. doi: 10.1111\/j.1365-2982.2008.01179.x","journal-title":"Neurogastroenterol Motil"},{"issue":"11","key":"9729_CR70","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/j.1365-2036.2009.03986.x","volume":"29","author":"N Ejskjaer","year":"2009","unstructured":"Ejskjaer N, Vestergaard ET, Hellstrom PM, Gormsen LC, Madsbad S, Madsen JL, Jensen TA, Pezzullo JC, Christiansen JS, Shaughnessy L, Kosutic G (2009) Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis. Aliment Pharmacol Ther 29(11):1179\u20131187. doi: 10.1111\/j.1365-2036.2009.03986.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"9729_CR71","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1111\/nmo.12064","volume":"25","author":"N Ejskjaer","year":"2013","unstructured":"Ejskjaer N, Wo JM, Esfandyari T, Mazen Jamal M, Dimcevski G, Tarnow L, Malik RA, Hellstrom PM, Mondou E, Quinn J, Rousseau F, McCallum RW (2013) A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis. Neurogastroenterol Motil 25(2):e140\u2013e150. doi: 10.1111\/nmo.12064","journal-title":"Neurogastroenterol Motil"},{"issue":"12","key":"9729_CR72","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/gut.2005.069088","volume":"54","author":"CD Murray","year":"2005","unstructured":"Murray CD, Martin NM, Patterson M, Taylor SA, Ghatei MA, Kamm MA, Johnston C, Bloom SR, Emmanuel AV (2005) Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 54(12):1693\u20131698. doi: 10.1136\/gut.2005.069088","journal-title":"Gut"},{"issue":"5","key":"9729_CR73","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1111\/j.1365-2982.2012.01904.x","volume":"24","author":"L Wang","year":"2012","unstructured":"Wang L, Murphy NP, Stengel A, Goebel-Stengel M, St Pierre DH, Maidment NT, Tache Y (2012) Ghrelin prevents levodopa-induced inhibition of gastric emptying and increases circulating levodopa in fasted rats. Neurogastroenterol Motil 24(5):e235\u2013e245. doi: 10.1111\/j.1365-2982.2012.01904.x","journal-title":"Neurogastroenterol Motil"},{"issue":"12","key":"9729_CR74","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1111\/nmo.12459","volume":"26","author":"H Karasawa","year":"2014","unstructured":"Karasawa H, Pietra C, Giuliano C, Garcia-Rubio S, Xu X, Yakabi S, Tache Y, Wang L (2014) New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson\u2019s disease. Neurogastroenterol Motil 26(12):1771\u20131782. doi: 10.1111\/nmo.12459","journal-title":"Neurogastroenterol Motil"},{"issue":"Suppl 17","key":"9729_CR75","doi-asserted-by":"publisher","first-page":"S367","DOI":"10.1002\/mds.21682","volume":"22","author":"CL Comella","year":"2007","unstructured":"Comella CL (2007) Sleep disorders in Parkinson\u2019s disease: an overview. Mov Disord 22(Suppl 17):S367\u2013S373. doi: 10.1002\/mds.21682","journal-title":"Mov Disord"},{"issue":"2","key":"9729_CR76","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1389-9457(01)00127-7","volume":"3","author":"WG Oerlemans","year":"2002","unstructured":"Oerlemans WG, de Weerd AW (2002) The prevalence of sleep disorders in patients with Parkinson\u2019s disease. A self-reported, community-based survey. Sleep Med 3(2):147\u2013149","journal-title":"Sleep Med"},{"key":"9729_CR77","doi-asserted-by":"publisher","unstructured":"Tholfsen LK, Larsen JP, Schulz J, Tysnes OB, Gjerstad MD (2015) Development of excessive daytime sleepiness in early Parkinson disease. Neurology. doi: 10.1212\/WNL.0000000000001737","DOI":"10.1212\/WNL.0000000000001737"},{"issue":"Suppl","key":"9729_CR78","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.parkreldis.2007.06.007","volume":"13","author":"E Tolosa","year":"2007","unstructured":"Tolosa E, Compta Y, Gaig C (2007) The premotor phase of Parkinson\u2019s disease. Parkinsonism Relat Disord 13(Suppl):S2\u2013S7. doi: 10.1016\/j.parkreldis.2007.06.007","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl 1","key":"9729_CR79","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","volume":"15","author":"W Poewe","year":"2008","unstructured":"Poewe W (2008) Non-motor symptoms in Parkinson\u2019s disease. Eur J Neurol 15(Suppl 1):14\u201320. doi: 10.1111\/j.1468-1331.2008.02056.x","journal-title":"Eur J Neurol"},{"issue":"7","key":"9729_CR80","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S1474-4422(06)70476-8","volume":"5","author":"A Iranzo","year":"2006","unstructured":"Iranzo A, Molinuevo JL, Santamaria J, Serradell M, Marti MJ, Valldeoriola F, Tolosa E (2006) Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 5(7):572\u2013577. doi: 10.1016\/S1474-4422(06)70476-8","journal-title":"Lancet Neurol"},{"issue":"Pt 12","key":"9729_CR81","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1093\/brain\/awu290","volume":"137","author":"P Wu","year":"2014","unstructured":"Wu P, Yu H, Peng S, Dauvilliers Y, Wang J, Ge J, Zhang H, Eidelberg D, Ma Y, Zuo C (2014) Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorder. Brain 137(Pt 12):3122\u20133128. doi: 10.1093\/brain\/awu290","journal-title":"Brain"},{"issue":"8","key":"9729_CR82","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.sleep.2012.10.009","volume":"14","author":"CH Schenck","year":"2013","unstructured":"Schenck CH, Boeve BF, Mahowald MW (2013) Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med 14(8):744\u2013748. doi: 10.1016\/j.sleep.2012.10.009","journal-title":"Sleep Med"},{"issue":"11","key":"9729_CR83","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1212\/WNL.0b013e31822e560e","volume":"77","author":"F Sixel-Doring","year":"2011","unstructured":"Sixel-Doring F, Trautmann E, Mollenhauer B, Trenkwalder C (2011) Associated factors for REM sleep behavior disorder in Parkinson disease. Neurology 77(11):1048\u20131054. doi: 10.1212\/WNL.0b013e31822e560e","journal-title":"Neurology"},{"issue":"8","key":"9729_CR84","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2337\/diabetes.50.8.1714","volume":"50","author":"DE Cummings","year":"2001","unstructured":"Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS (2001) A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50(8):1714\u20131719","journal-title":"Diabetes"},{"issue":"6","key":"9729_CR85","doi-asserted-by":"publisher","first-page":"E963","DOI":"10.1152\/ajpendo.00527.2003","volume":"286","author":"A Dzaja","year":"2004","unstructured":"Dzaja A, Dalal MA, Himmerich H, Uhr M, Pollmacher T, Schuld A (2004) Sleep enhances nocturnal plasma ghrelin levels in healthy subjects. Am J Physiol Endocrinol Metab 286(6):E963\u2013E967. doi: 10.1152\/ajpendo.00527.2003","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"9729_CR86","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3233\/BEN-2011-0329","volume":"24","author":"LX Blonder","year":"2011","unstructured":"Blonder LX, Slevin JT (2011) Emotional dysfunction in Parkinson\u2019s disease. Behav Neurol 24(3):201\u2013217. doi: 10.3233\/BEN-2011-0329","journal-title":"Behav Neurol"},{"issue":"7","key":"9729_CR87","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/mds.20844","volume":"21","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, Brown RG, Koller W, Barone P, MacPhee G, Kelly L, Rabey M, MacMahon D, Thomas S, Ondo W, Rye D, Forbes A, Tluk S, Dhawan V, Bowron A, Williams AJ, Olanow CW (2006) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson\u2019s disease: the NMSQuest study. Mov Disord 21(7):916\u2013923. doi: 10.1002\/mds.20844","journal-title":"Mov Disord"},{"issue":"1","key":"9729_CR88","first-page":"81","volume":"4","author":"PG Frisina","year":"2008","unstructured":"Frisina PG, Borod JC, Foldi NS, Tenenbaum HR (2008) Depression in Parkinson\u2019s disease: health risks, etiology, and treatment options. Neuropsychiatr Dis Treat 4(1):81\u201391","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"22","key":"9729_CR89","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3923\/pjbs.2012.1063.1068","volume":"15","author":"F Kajbaf","year":"2012","unstructured":"Kajbaf F, Ahmadi R, Fatemi Tabatabaie R, Safarpoor E (2012) Effect of intrahippocampal ghrelin agonist administration on passive avoidance learning and anxiety in rats. Pak J Biol Sci 15(22):1063\u20131068","journal-title":"Pak J Biol Sci"},{"issue":"7","key":"9729_CR90","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/nn.2139","volume":"11","author":"M Lutter","year":"2008","unstructured":"Lutter M, Sakata I, Osborne-Lawrence S, Rovinsky SA, Anderson JG, Jung S, Birnbaum S, Yanagisawa M, Elmquist JK, Nestler EJ, Zigman JM (2008) The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat Neurosci 11(7):752\u2013753. doi: 10.1038\/nn.2139","journal-title":"Nat Neurosci"},{"issue":"6","key":"9729_CR91","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.biopsych.2012.03.010","volume":"72","author":"SJ Spencer","year":"2012","unstructured":"Spencer SJ, Xu L, Clarke MA, Lemus M, Reichenbach A, Geenen B, Kozicz T, Andrews ZB (2012) Ghrelin regulates the hypothalamic-pituitary-adrenal axis and restricts anxiety after acute stress. Biol Psychiatry 72(6):457\u2013465. doi: 10.1016\/j.biopsych.2012.03.010","journal-title":"Biol Psychiatry"},{"issue":"5","key":"9729_CR92","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0006-291X(02)02740-7","volume":"299","author":"VP Carlini","year":"2002","unstructured":"Carlini VP, Monzon ME, Varas MM, Cragnolini AB, Schioth HB, Scimonelli TN, de Barioglio SR (2002) Ghrelin increases anxiety-like behavior and memory retention in rats. Biochem Biophys Res Commun 299(5):739\u2013743","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"9729_CR93","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.nlm.2008.12.008","volume":"91","author":"P Carvajal","year":"2009","unstructured":"Carvajal P, Carlini VP, Schioth HB, de Barioglio SR, Salvatierra NA (2009) Central ghrelin increases anxiety in the open field test and impairs retention memory in a passive avoidance task in neonatal chicks. Neurobiol Learn Mem 91(4):402\u2013407. doi: 10.1016\/j.nlm.2008.12.008","journal-title":"Neurobiol Learn Mem"},{"issue":"1","key":"9729_CR94","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bbr.2011.08.037","volume":"226","author":"PJ Currie","year":"2012","unstructured":"Currie PJ, Khelemsky R, Rigsbee EM, Dono LM, Coiro CD, Chapman CD, Hinchcliff K (2012) Ghrelin is an orexigenic peptide and elicits anxiety-like behaviors following administration into discrete regions of the hypothalamus. Behav Brain Res 226(1):96\u2013105. doi: 10.1016\/j.bbr.2011.08.037","journal-title":"Behav Brain Res"},{"issue":"6","key":"9729_CR95","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1210\/en.2005-1182","volume":"147","author":"TO Mundinger","year":"2006","unstructured":"Mundinger TO, Cummings DE, Taborsky GJ Jr (2006) Direct stimulation of ghrelin secretion by sympathetic nerves. Endocrinology 147(6):2893\u20132901. doi: 10.1210\/en.2005-1182","journal-title":"Endocrinology"},{"issue":"3","key":"9729_CR96","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.bbrc.2003.11.150","volume":"313","author":"VP Carlini","year":"2004","unstructured":"Carlini VP, Varas MM, Cragnolini AB, Schioth HB, Scimonelli TN, de Barioglio SR (2004) Differential role of the hippocampus, amygdala, and dorsal raphe nucleus in regulating feeding, memory, and anxiety-like behavioral responses to ghrelin. Biochem Biophys Res Commun 313(3):635\u2013641","journal-title":"Biochem Biophys Res Commun"},{"issue":"10-11","key":"9729_CR97","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.clinbiochem.2009.02.020","volume":"42","author":"AO Barim","year":"2009","unstructured":"Barim AO, Aydin S, Colak R, Dag E, Deniz O, Sahin I (2009) Ghrelin, paraoxonase and arylesterase levels in depressive patients before and after citalopram treatment. Clin Biochem 42(10-11):1076\u20131081. doi: 10.1016\/j.clinbiochem.2009.02.020","journal-title":"Clin Biochem"},{"issue":"5","key":"9729_CR98","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1079\/BJN20051678","volume":"95","author":"JB Corcuff","year":"2006","unstructured":"Corcuff JB, Krim E, Tison F, Foubert-Sanier A, Guehl D, Burbaud P, Cuny E, Baillet L, Gin H, Rigalleau V, Perlemoine C (2006) Subthalamic nucleus stimulation in patients with Parkinson\u2019s disease does not increase serum ghrelin levels. Br J Nutr 95(5):1028\u20131029","journal-title":"Br J Nutr"},{"issue":"4","key":"9729_CR99","first-page":"437","volume":"32","author":"L Novakova","year":"2011","unstructured":"Novakova L, Haluzik M, Jech R, Urgosik D, Ruzicka F, Ruzicka E (2011) Hormonal regulators of food intake and weight gain in Parkinson\u2019s disease after subthalamic nucleus stimulation. Neuro Endocrinol Lett 32(4):437\u2013441","journal-title":"Neuro Endocrinol Lett"},{"issue":"2","key":"9729_CR100","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000335045","volume":"90","author":"E Markaki","year":"2012","unstructured":"Markaki E, Ellul J, Kefalopoulou Z, Trachani E, Theodoropoulou A, Kyriazopoulou V, Constantoyannis C (2012) The role of ghrelin, neuropeptide Y and leptin peptides in weight gain after deep brain stimulation for Parkinson\u2019s disease. Stereotact Funct Neurosurg 90(2):104\u2013112. doi: 10.1159\/000335045","journal-title":"Stereotact Funct Neurosurg"},{"issue":"5580","key":"9729_CR101","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297(5580):353\u2013356. doi: 10.1126\/science.1072994","journal-title":"Science"},{"issue":"4","key":"9729_CR102","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nm0406-392","volume":"12","author":"S Maudsley","year":"2006","unstructured":"Maudsley S, Mattson MP (2006) Protein twists and turns in Alzheimer disease. Nat Med 12(4):392\u2013393. doi: 10.1038\/nm0406-392","journal-title":"Nat Med"},{"issue":"1","key":"9729_CR103","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/156720512799015064","volume":"9","author":"H Cai","year":"2012","unstructured":"Cai H, Cong WN, Ji S, Rothman S, Maudsley S, Martin B (2012) Metabolic dysfunction in Alzheimer\u2019s disease and related neurodegenerative disorders. Curr Alzheimer Res 9(1):5\u201317","journal-title":"Curr Alzheimer Res"},{"issue":"3","key":"9729_CR104","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nn1656","volume":"9","author":"S Diano","year":"2006","unstructured":"Diano S, Farr SA, Benoit SC, McNay EC, da Silva I, Horvath B, Gaskin FS, Nonaka N, Jaeger LB, Banks WA, Morley JE, Pinto S, Sherwin RS, Xu L, Yamada KA, Sleeman MW, Tschop MH, Horvath TL (2006) Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 9(3):381\u2013388. doi: 10.1038\/nn1656","journal-title":"Nat Neurosci"},{"issue":"1","key":"9729_CR105","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3233\/JAD-132417","volume":"41","author":"M Moon","year":"2014","unstructured":"Moon M, Cha MY, Mook-Jung I (2014) Impaired hippocampal neurogenesis and its enhancement with ghrelin in 5XFAD mice. J Alzheimers Dis 41(1):233\u2013241. doi: 10.3233\/JAD-132417","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"9729_CR106","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/jne.12138","volume":"26","author":"S Gomes","year":"2014","unstructured":"Gomes S, Martins I, Fonseca AC, Oliveira CR, Resende R, Pereira CM (2014) Protective effect of leptin and ghrelin against toxicity induced by amyloid-beta oligomers in a hypothalamic cell line. J Neuroendocrinol 26(3):176\u2013185. doi: 10.1111\/jne.12138","journal-title":"J Neuroendocrinol"},{"key":"9729_CR107","doi-asserted-by":"publisher","unstructured":"Cecarini V, Bonfili L, Cuccioloni M, Keller JN, Bruce-Keller AJ, Eleuteri AM (2015) Effects of ghrelin on the proteolytic pathways of Alzheimer\u2019s disease neuronal cells. Mol Neurobiol. doi: 10.1007\/s12035-015-9227-x","DOI":"10.1007\/s12035-015-9227-x"},{"issue":"7","key":"9729_CR108","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1248\/bpb.33.1165","volume":"33","author":"Y Chen","year":"2010","unstructured":"Chen Y, Cao CP, Li CR, Wang W, Zhang D, Han LL, Zhang XQ, Kim A, Kim S, Liu GL (2010) Ghrelin modulates insulin sensitivity and tau phosphorylation in high glucose-induced hippocampal neurons. Biol Pharm Bull 33(7):1165\u20131169","journal-title":"Biol Pharm Bull"},{"key":"9729_CR109","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.peptides.2015.07.005","volume":"71","author":"S Kang","year":"2015","unstructured":"Kang S, Moon NR, da Kim S, Kim SH, Park S (2015) Central acylated ghrelin improves memory function and hippocampal AMPK activation and partly reverses the impairment of energy and glucose metabolism in rats infused with beta-amyloid. Peptides 71:84\u201393. doi: 10.1016\/j.peptides.2015.07.005","journal-title":"Peptides"},{"issue":"4","key":"9729_CR110","doi-asserted-by":"publisher","first-page":"e60437","DOI":"10.1371\/journal.pone.0060437","volume":"8","author":"EJ Dhurandhar","year":"2013","unstructured":"Dhurandhar EJ, Allison DB, van Groen T, Kadish I (2013) Hunger in the absence of caloric restriction improves cognition and attenuates Alzheimer\u2019s disease pathology in a mouse model. PLoS One 8(4):e60437. doi: 10.1371\/journal.pone.0060437","journal-title":"PLoS One"},{"issue":"3","key":"9729_CR111","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3233\/JAD-2010-100873","volume":"22","author":"MD Gahete","year":"2010","unstructured":"Gahete MD, Rubio A, Cordoba-Chacon J, Gracia-Navarro F, Kineman RD, Avila J, Luque RM, Castano JP (2010) Expression of the ghrelin and neurotensin systems is altered in the temporal lobe of Alzheimer\u2019s disease patients. J Alzheimers Dis 22(3):819\u2013828. doi: 10.3233\/JAD-2010-100873","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"9729_CR112","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/09513590500519385","volume":"22","author":"C Proto","year":"2006","unstructured":"Proto C, Romualdi D, Cento RM, Spada RS, Di Mento G, Ferri R, Lanzone A (2006) Plasma levels of neuropeptides in Alzheimer\u2019s disease. Gynecol Endocrinol 22(4):213\u2013218. doi: 10.1080\/09513590500519385","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"9729_CR113","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s12603-012-0058-4","volume":"16","author":"A Theodoropoulou","year":"2012","unstructured":"Theodoropoulou A, Metallinos IC, Psyrogiannis A, Vagenakis GA, Kyriazopoulou V (2012) Ghrelin and leptin secretion in patients with moderate Alzheimer\u2019s disease. J Nutr Health Aging 16(5):472\u2013477","journal-title":"J Nutr Health Aging"},{"issue":"3","key":"9729_CR114","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000333075","volume":"32","author":"N Shibata","year":"2011","unstructured":"Shibata N, Ohnuma T, Kuerban B, Komatsu M, Arai H (2011) Genetic association between ghrelin polymorphisms and Alzheimer\u2019s disease in a Japanese population. Dement Geriatr Cogn Disord 32(3):178\u2013181. doi: 10.1159\/000333075","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"9","key":"9729_CR115","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jalz.2014.08.104","volume":"11","author":"C Benedict","year":"2015","unstructured":"Benedict C, Byberg L, Cedernaes J, Hogenkamp PS, Giedratis V, Kilander L, Lind L, Lannfelt L, Schioth HB (2015) Self-reported sleep disturbance is associated with Alzheimer\u2019s disease risk in men. Alzheimers Dement 11(9):1090\u20131097. doi: 10.1016\/j.jalz.2014.08.104","journal-title":"Alzheimers Dement"},{"issue":"2","key":"9729_CR116","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrneurol.2013.269","volume":"10","author":"YE Ju","year":"2014","unstructured":"Ju YE, Lucey BP, Holtzman DM (2014) Sleep and Alzheimer disease pathology\u2014a bidirectional relationship. Nat Rev Neurol 10(2):115\u2013119. doi: 10.1038\/nrneurol.2013.269","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"9729_CR117","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/eje.0.1510451","volume":"151","author":"V Popovic","year":"2004","unstructured":"Popovic V, Svetel M, Djurovic M, Petrovic S, Doknic M, Pekic S, Miljic D, Milic N, Glodic J, Dieguez C, Casanueva FF, Kostic V (2004) Circulating and cerebrospinal fluid ghrelin and leptin: potential role in altered body weight in Huntington\u2019s disease. Eur J Endocrinol 151(4):451\u2013455","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"9729_CR118","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1468-1331.2009.02798.x","volume":"17","author":"NA Aziz","year":"2010","unstructured":"Aziz NA, Pijl H, Frolich M, Schroder-van der Elst JP, van der Bent C, Roelfsema F, Roos RA (2010) Growth hormone and ghrelin secretion are associated with clinical severity in Huntington\u2019s disease. Eur J Neurol 17(2):280\u2013288. doi: 10.1111\/j.1468-1331.2009.02798.x","journal-title":"Eur J Neurol"},{"key":"9729_CR119","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fphys.2014.00231","volume":"5","author":"R Wang","year":"2014","unstructured":"Wang R, Ross CA, Cai H, Cong WN, Daimon CM, Carlson OD, Egan JM, Siddiqui S, Maudsley S, Martin B (2014) Metabolic and hormonal signatures in pre-manifest and manifest Huntington\u2019s disease patients. Front Physiol 5:231. doi: 10.3389\/fphys.2014.00231","journal-title":"Front Physiol"},{"issue":"1","key":"9729_CR120","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11033-012-1993-1","volume":"40","author":"R Zhang","year":"2013","unstructured":"Zhang R, Yang G, Wang Q, Guo F, Wang H (2013) Acylated ghrelin protects hippocampal neurons in pilocarpine-induced seizures of immature rats by inhibiting cell apoptosis. Mol Biol Rep 40(1):51\u201358. doi: 10.1007\/s11033-012-1993-1","journal-title":"Mol Biol Rep"},{"issue":"3","key":"9729_CR121","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1677\/JOE-10-0040","volume":"205","author":"J Lee","year":"2010","unstructured":"Lee J, Lim E, Kim Y, Li E, Park S (2010) Ghrelin attenuates kainic acid-induced neuronal cell death in the mouse hippocampus. J Endocrinol 205(3):263\u2013270. doi: 10.1677\/JOE-10-0040","journal-title":"J Endocrinol"},{"issue":"1","key":"9729_CR122","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.expneurol.2011.04.003","volume":"230","author":"E Lim","year":"2011","unstructured":"Lim E, Lee S, Li E, Kim Y, Park S (2011) Ghrelin protects spinal cord motoneurons against chronic glutamate-induced excitotoxicity via ERK1\/2 and phosphatidylinositol-3-kinase\/Akt\/glycogen synthase kinase-3beta pathways. Exp Neurol 230(1):114\u2013122. doi: 10.1016\/j.expneurol.2011.04.003","journal-title":"Exp Neurol"},{"issue":"4","key":"9729_CR123","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1528-1167.2012.03423.x","volume":"53","author":"J Portelli","year":"2012","unstructured":"Portelli J, Michotte Y, Smolders I (2012) Ghrelin: an emerging new anticonvulsant neuropeptide. Epilepsia 53(4):585\u2013595. doi: 10.1111\/j.1528-1167.2012.03423.x","journal-title":"Epilepsia"},{"issue":"1","key":"9729_CR124","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3390\/brainsci3010344","volume":"3","author":"SJ Spencer","year":"2013","unstructured":"Spencer SJ, Miller AA, Andrews ZB (2013) The role of ghrelin in neuroprotection after ischemic brain injury. Brain Sci 3(1):344\u2013359. doi: 10.3390\/brainsci3010344","journal-title":"Brain Sci"},{"issue":"1-2","key":"9729_CR125","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jns.2015.06.053","volume":"357","author":"ST Ngo","year":"2015","unstructured":"Ngo ST, Steyn FJ, Huang L, Mantovani S, Pfluger CM, Woodruff TM, O\u2019Sullivan JD, Henderson RD, McCombe PA (2015) Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis. J Neurol Sci 357(1-2):22\u201327. doi: 10.1016\/j.jns.2015.06.053","journal-title":"J Neurol Sci"},{"issue":"Pt A","key":"9729_CR126","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.nbd.2014.08.026","volume":"72","author":"II Stoyanova","year":"2014","unstructured":"Stoyanova II (2014) Ghrelin: a link between ageing, metabolism and neurodegenerative disorders. Neurobiol Dis 72(Pt A):72\u201383. doi: 10.1016\/j.nbd.2014.08.026","journal-title":"Neurobiol Dis"},{"issue":"1-2","key":"9729_CR127","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11010-009-0073-x","volume":"328","author":"S Aydin","year":"2009","unstructured":"Aydin S, Dag E, Ozkan Y, Erman F, Dagli AF, Kilic N, Sahin I, Karatas F, Yoldas T, Barim AO, Kendir Y (2009) Nesfatin-1 and ghrelin levels in serum and saliva of epileptic patients: hormonal changes can have a major effect on seizure disorders. Mol Cell Biochem 328(1-2):49\u201356. doi: 10.1007\/s11010-009-0073-x","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"9729_CR128","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.seizure.2005.11.008","volume":"15","author":"MS Berilgen","year":"2006","unstructured":"Berilgen MS, Mungen B, Ustundag B, Demir C (2006) Serum ghrelin levels are enhanced in patients with epilepsy. Seizure 15(2):106\u2013111. doi: 10.1016\/j.seizure.2005.11.008","journal-title":"Seizure"},{"issue":"5","key":"9729_CR129","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.peptides.2010.02.009","volume":"31","author":"E Dag","year":"2010","unstructured":"Dag E, Aydin S, Ozkan Y, Erman F, Dagli AF, Gurger M (2010) Alteration in chromogranin A, obestatin and total ghrelin levels of saliva and serum in epilepsy cases. Peptides 31(5):932\u2013937. doi: 10.1016\/j.peptides.2010.02.009","journal-title":"Peptides"},{"issue":"11","key":"9729_CR130","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1212\/01.wnl.0000187074.27586.d1","volume":"65","author":"R Greco","year":"2005","unstructured":"Greco R, Latini G, Chiarelli F, Iannetti P, Verrotti A (2005) Leptin, ghrelin, and adiponectin in epileptic patients treated with valproic acid. Neurology 65(11):1808\u20131809. doi: 10.1212\/01.wnl.0000187074.27586.d1","journal-title":"Neurology"},{"issue":"2","key":"9729_CR131","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/ar.21490","volume":"295","author":"X Xu","year":"2012","unstructured":"Xu X, Zhu Y, Chuai J (2012) Changes in serum ghrelin and small intestinal motility in rats with ischemic stroke. Anat Rec (Hoboken) 295(2):307\u2013312. doi: 10.1002\/ar.21490","journal-title":"Anat Rec (Hoboken)"},{"key":"9729_CR132","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.peptides.2014.01.021","volume":"54","author":"Z Xu","year":"2014","unstructured":"Xu Z, Lv XA, Wang JW, Chen ZP, Qiu HS (2014) Predictive value of early decreased plasma ghrelin level for three-month cognitive deterioration in patients with mild traumatic brain injury. Peptides 54:180\u2013185. doi: 10.1016\/j.peptides.2014.01.021","journal-title":"Peptides"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9729-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-016-9729-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9729-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9729-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T11:20:53Z","timestamp":1589628053000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-016-9729-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,26]]},"references-count":132,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["9729"],"URL":"https:\/\/doi.org\/10.1007\/s12035-016-9729-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,26]]}}}